Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > What’s this thing worth at full value assuming.........

<< Previous

Bullboard Posts

Next >>

Comment by Arrakis37on Aug 01, 2020 11:55am

169 Views

Post# 31353758

RE:RE:RE:What’s this thing worth at full value assuming.........

I didn't neglect the reverse split, I was responding to Transit77

stockman6767 wrote:

2600$ a share will give you 61.4 billion market cap. The only question you have to ask is : Can a company with this poor management is able to reach that level ?

Arrakis, you neglected to figure the mere factor of 1000 for the reverse split a year ago, thus you get 61.4 Billion market cap (using your number) divided by 1000 = 614 Million market cap! If you make an argument, get it right.